RxDoctor Payments Data

Kohlbe Thomas, PA

Physician Assistant · Denver, CONPI 1346707908

Payments from drug & device makers

$1,632in general payments, 2019–2025

Across 83 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$222
  • Novo Nordisk$207
  • Pfizer$113
  • Lilly USA, LLC$99
  • AstraZeneca$98
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$94
  • plus $799 from 21 others

What the payments were for

  • Food & beverage$1,60598%
  • Education$272%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,632 in reported general payments places this provider in the 80th percentile of 2,849 physician assistant providers in Colorado.

See all physician assistant providers in Colorado

Medicare billing

Part B allowed, 2024
$17,743
Medicare patients
115
Services billed
225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl28$20,859
Nurtec OdtRimegepant Sulfate12$19,761
Buprenorphine20$4,367
Gabapentin188$2,754
Diclofenac Sodium41$2,678
Lidocaine31$2,534
Tramadol Hcl ErTramadol Hcl26$1,846
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl15$1,436
Pregabalin77$1,258
Cyclobenzaprine Hcl74$683
Methocarbamol42$531
Ondansetron OdtOndansetron25$510
Tramadol Hcl65$495
Celecoxib17$483
Tizanidine Hcl54$475

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$31$20,85928 claims
PfizerNurtec Odt$113$19,76112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,849 physician assistant providers in Colorado.

Other physician assistant in Denver

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →